Abstract
The purpose of this study is to understand the early pregnancy action of arginine vasopressin (AVP), as measured by its stable byproduct of copeptin, to develop preventative, and therapeutic modalities against preeclampsia (PreE).
Sigma Membership
Gamma, Gamma Gamma
Lead Author Affiliation
The University of Iowa, Iowa City, Iowa, USA
Type
Report
Format Type
Text-based Document
Study Design/Type
Other
Research Approach
Pilot/Exploratory Study
Keywords:
Vasopressin, Depression Symptoms, Pain, Preeclampsia
Recommended Citation
Vignato, Julie A.; Scroggins, Sabrina; Brandt, Debra; Thomas, Kellie; Santillan, Donna; and Santillan, Mark, "Vasopressin, depression symptoms, pain and preeclampsia" (2020). Sigma Foundation for Nursing Research Grant Reports. 7.
https://www.sigmarepository.org/grant_reports/7
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Review Type
None: Sigma Grant Recipient Report
Acquisition
Self-submission
Date of Issue
2020-01-08
Full Text of Presentation
wf_yes
